Skip to main content

Table 1 Subject characteristics presented for the overall cohort and by CTO status

From: Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study

  Overall cohort
(n = 1211; 100%)
CTO status
pre = no/post = no
(n = 689; 57%)
pre = yes/post = yes
(n = 275; 23%)
pre = yes/post = no
(n = 133; 11%)
pre = no/post = yes
(n = 114; 9%)
Age, years
 Mean (SD) 38 (14) 39 (14) 38 (14) 38 (12) 34 (14)
Categories, n (%)
 18–24 239 (19.7%) 134 (19.5%) 44 (16.0%) 24 (18.1%) 37 (32.5%)
 25–29 196 (16.2%) 101 (14.7%) 58 (21.1%) 18 (13.5%) 19 (16.7%)
 30–34 150 (12.4%) 95 (13.8%) 27 (9.8%) 14 (10.5%) 14 (12.3%)
 35–39 132 (10.9%) 64 (9.3%) 43 (15.6%) 15 (11.3%) 10 (8.8%)
 40–44 124 (10.2%) 64 (9.3%) 26 (9.5%) 24 (18.1%) 10 (8.8%)
 45–49 105 (8.7%) 66 (9.6%) 17 (6.2%) 15 (11.3%)  < 10 (< 8.8%)
 50–54 101 (8.3%) 63 (9.1%) 22 (8.0%) 12 (9.0%)  < 10 (< 8.8%)
 55–59 69 (5.7%) 43 (6.2%) 15 (5.5%)  < 10 (< 7.5%)  < 10 (< 8.8%)
 60–64 40 (3.3%) 25 (3.6%)  < 15 (< 5.5%)  < 10 (< 7.5%)  < 10 (< 8.8%)
  ≥ 65 55 (4.5%) 34 (4.9%)  < 15 (< 5.5%)  < 10 (< 7.5%)  < 10 (< 8.8%)
Sex, n (%)
 Male 779 (64.3%) 436 (63.3%) 177 (64.4%) 84 (63.2%) 82 (71.9%)
 Female 432 (35.7%) 253 (36.7%) 98 (35.6%) 49 (36.8%) 32 (28.1%)
Residence, n (%)
 Urban 1078 (89.0%) 608 (88.2%) 252 (91.6%) 118 (88.7%) 100 (87.7%)
 Rural 133 (11.0%) 81 (11.8%) 23 (8.4%) 15 (11.3%) 14 (12.3%)
CCI, mean (SD) 0.6 (1.3) 0.7 (1.4) 0.5 (1.0) 0.6 (1.3) 0.6 (1.0)
Hospitalized on index date, n (%) 161 (13.3%) 87 (12.6%) 36 (13.1%)  < 10 (< 7.5%) 31 (27.2%)
Index SGA-LAI, n (%)
 Paliperidone 833 (68.8%) 471 (68.4%) 186 (67.6%) 95 (71.4%) 81 (71.1%)
 Aripiprazole 229 (18.8%) 126 (18.3%) 58 (21.1%) 26 (19.5%) 19 (16.7%)
 Risperidone 149 (12.3%) 92 (13.4%) 31 (11.3%) 14 (11.3%) 14 (12.3%)
  1. Abbreviations: CCI Charlson comorbidity index, CTO Community treatment order, SD Standard deviation, SGA-LAI Second generation antipsychotic long-acting injectable. Subject numbers less than 10 need to be redacted as per data privacy standards, and prevented from being back-calculated